IR-Med, Inc. Files 8-K for Reg FD and Financials
Ticker: IRME · Form: 8-K · Filed: Sep 17, 2024 · CIK: 1839133
| Field | Detail |
|---|---|
| Company | Ir-Med, Inc. (IRME) |
| Form Type | 8-K |
| Filed Date | Sep 17, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
TL;DR
IR-Med filed an 8-K for Reg FD and financials. No juicy details yet.
AI Summary
IR-Med, Inc. filed an 8-K on September 17, 2024, to report on a Regulation FD disclosure and financial statements/exhibits. The company, formerly known as International Display Advertising, Inc., is incorporated in Nevada and has its principal executive offices in Rosh Pina, Israel. The filing does not contain specific financial figures or details about the Regulation FD disclosure.
Why It Matters
This filing indicates IR-Med, Inc. is providing updates to the SEC regarding regulatory disclosures and financial information, which is standard for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine filing for an 8-K, primarily indicating the submission of required disclosures and financial information without any immediate material events.
Key Players & Entities
- IR-Med, Inc. (company) — Filer
- September 17, 2024 (date) — Filing date
- International Display Advertising, Inc. (company) — Former company name
- Nevada (jurisdiction) — State of incorporation
- Rosh Pina Israel (location) — Principal Executive Offices
FAQ
What specific information was disclosed under Regulation FD?
The filing states it is a Regulation FD Disclosure, but the specific details of the disclosure are not provided within the provided text.
What financial statements or exhibits are included in this filing?
The filing indicates that Financial Statements and Exhibits are included, but the content of these documents is not detailed in the provided text.
When did IR-Med, Inc. change its name from International Display Advertising, Inc.?
The company's name was changed on January 5, 2021.
What is the principal executive office address for IR-Med, Inc.?
The principal executive offices are located at ZHR Industrial Zone Rosh Pina Israel.
What is the SIC code for IR-Med, Inc.?
The Standard Industrial Classification (SIC) code for IR-Med, Inc. is 3845, which corresponds to Electromedical & Electrotherapeutic Apparatus.
Filing Stats: 384 words · 2 min read · ~1 pages · Grade level 12.2 · Accepted 2024-09-17 17:21:08
Filing Documents
- form8-k.htm (8-K) — 36KB
- ex99-1.htm (EX-99.1) — 14KB
- ex99-1_001.jpg (GRAPHIC) — 363KB
- ex99-1_002.jpg (GRAPHIC) — 596KB
- ex99-1_003.jpg (GRAPHIC) — 468KB
- ex99-1_004.jpg (GRAPHIC) — 408KB
- ex99-1_005.jpg (GRAPHIC) — 348KB
- ex99-1_006.jpg (GRAPHIC) — 347KB
- ex99-1_007.jpg (GRAPHIC) — 451KB
- ex99-1_008.jpg (GRAPHIC) — 423KB
- ex99-1_009.jpg (GRAPHIC) — 441KB
- ex99-1_010.jpg (GRAPHIC) — 434KB
- ex99-1_011.jpg (GRAPHIC) — 477KB
- ex99-1_012.jpg (GRAPHIC) — 469KB
- ex99-1_013.jpg (GRAPHIC) — 312KB
- ex99-1_014.jpg (GRAPHIC) — 532KB
- ex99-1_015.jpg (GRAPHIC) — 520KB
- ex99-1_016.jpg (GRAPHIC) — 504KB
- ex99-1_017.jpg (GRAPHIC) — 536KB
- ex99-1_018.jpg (GRAPHIC) — 343KB
- ex99-1_019.jpg (GRAPHIC) — 457KB
- ex99-1_020.jpg (GRAPHIC) — 319KB
- ex99-1_021.jpg (GRAPHIC) — 186KB
- 0001493152-24-036890.txt ( ) — 12523KB
- irme-20240917.xsd (EX-101.SCH) — 3KB
- irme-20240917_lab.xml (EX-101.LAB) — 33KB
- irme-20240917_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure. On September 17, 2024, IR-Med, Inc. posted to its website an updated investor presentation, a copy of which is attached hereto as Exhibit 99.1.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 99.1 Investor presentation (furnished herewith) 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IR-Med, Inc. By: /s/ Sharon Levkoviz Name: Sharon Levkoviz Title: Chief Financial Officer Date: September 17, 2024